Ensartinib

1370651-20-9

C-Met/HGFR, ALK

Angiogenesis, Tyrosine Kinase/Adaptors

0.9992

Ensartinib (X-396) is a potent and orally active dual ALK/MET inhibitor for the treatment of ALK-positive non-small cell lung cancer (NSCLC) .

C(=O)(N1C[C@@H](C)N[C@@H](C)C1)C2=CC=C(NC(=O)C3=CC(O[C@H](C)C4=C(Cl)C(F)=CC=C4Cl)=C(N)N=N3)C=C2

C26H27Cl2FN6O3

561.44

Ice Packs

-20°C